Prospective Study Confirms that Radioiodine Remnant Ablation Is Not Necessary in Low-Risk Differentiated Thyroid Cancer

Publisher： Karger

E-ISSN： 2235-0802|5|1|7-8

ISSN： 2235-0640

Source： European Thyroid Journal, Vol.5, Iss.1, 2016-01, pp. : 7-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy

By  

European Thyroid Journal, Vol. 5, Iss. 1, 2015-11 ,pp. : 44-49

Karger

Access to resources Recommend Favorite

Radioiodine Treatment and Thyroid Hormone Suppression Therapy for Differentiated Thyroid Carcinoma: Adverse Effects Support the Trend toward Less Aggressive Treatment for Low-Risk Patients

By  

European Thyroid Journal, Vol. 4, Iss. 2, 2015-06 ,pp. : 82-92

Karger

Access to resources Recommend Favorite

Radioiodine Ablation following Thyroidectomy for Differentiated Thyroid Cancer: Literature Review of Utility, Dose, and Toxicity


By  

European Thyroid Journal, Vol. 6, Iss. 4, 2017-03 ,pp. : 187-196

Karger

Access to resources Recommend Favorite

Can the American Thyroid Association Risk of Recurrence Predict Radioiodine Refractory Disease in Differentiated Thyroid Cancer?

By  

European Thyroid Journal, Vol. 5, Iss. 4, 2016-10 ,pp. : 261-267

Karger

Access to resources Recommend Favorite

Use of Pre-Ablation Radioiodine-131 Scan to Assess the Impact of Surgical Volume and Specialisation following Thyroidectomy for Differentiated Thyroid Carcinoma

By  

European Thyroid Journal, Vol. 2, Iss. 4, 2013-11 ,pp. : 275-281

Karger

Access to resources Recommend Favorite